HCPCS Level II code Q2039 represents an influenza virus vaccine, not otherwise specified, used for administration of seasonal influenza immunization; the service is a vaccine product for prevention of influenza and is typically provided in outpatient and clinic settings, including physician offices, pharmacies, and community health clinics.

For related coverage guidance, see recent payer policy updates: B-Hemolytic Streptococcus Testing, Human Immunodeficiency Virus (HIV) — Coverage Criteria for Testing and Resistance Assays, Hepatitis Testing (A, B, C, D) Coverage Criteria.